PAVmed Capital Surpluse vs Net Working Capital Analysis

PAVM Stock

USD 0.79 0.13 19.70%

PAVmed financial indicator trend analysis is much more than just breaking down PAVmed Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PAVmed Inc is a good investment. Please check the relationship between PAVmed Capital Surpluse and its Net Working Capital accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Capital Surpluse vs Net Working Capital

Capital Surpluse vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PAVmed Inc Capital Surpluse account and Net Working Capital. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between PAVmed's Capital Surpluse and Net Working Capital is -0.11. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of PAVmed Inc, assuming nothing else is changed. The correlation between historical values of PAVmed's Capital Surpluse and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of PAVmed Inc are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Capital Surpluse i.e., PAVmed's Capital Surpluse and Net Working Capital go up and down completely randomly.

Correlation Coefficient

-0.11

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capital Surpluse

Net Working Capital

Most indicators from PAVmed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PAVmed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

At this time, PAVmed's Selling General Administrative is very stable compared to the past year. As of the 16th of February 2025, Issuance Of Capital Stock is likely to grow to about 29.4 M, while Sales General And Administrative To Revenue is likely to drop 13.79.

	2024	2025 (projected)
Total Operating Expenses	74.6M	78.3M
Non Recurring	236.9K	210.6K

Total Operating Expenses Non Recurring

PAVmed fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Property Plant And Equipment Net	Retained Earnings Total Equity	Property Plant And Equipment Gross	Property Plant Equipment
Total Assets		0.33	0.48	0.19	0.43	-0.49	-0.69	0.78	0.99	0.99	0.8	-0.02	0.82	-0.11	0.76	0.48	0.99	0.73	0.66	0.58	0.32	0.75	0.55	-0.87	0.53	0.57
Other Current Liab	0.33		0.49	-0.38	-0.14	0.17	-0.52	0.03	0.26	0.26	0.39	0.17	0.5	0.01	0.53	0.5	0.28	-0.2	0.62	0.39	-0.45	0.15	0.64	-0.36	0.64	0.64
Total Current Liabilities	0.48	0.49		-0.75	-0.5	0.51	-0.95	0.54	0.36	0.36	0.89	0.07	0.89	-0.06	0.93	1.0	0.4	0.08	0.94	0.88	-0.24	-0.11	0.97	-0.82	0.97	0.96
Total Stockholder Equity	0.19	-0.38	-0.75		0.89	-0.94	0.58	0.03	0.33	0.33	-0.37	-0.08	-0.38	0.02	-0.46	-0.75	0.28	0.48	-0.57	-0.54	0.53	0.68	-0.68	0.28	-0.71	-0.67
Net Tangible Assets	0.43	-0.14	-0.5	0.89		-0.96	0.29	0.16	0.56	0.56	-0.1	-0.11	-0.09	-0.07	-0.16	-0.51	0.52	0.41	-0.32	-0.29	0.32	0.91	-0.42	0.01	-0.43	-0.42
Net Debt	-0.49	0.17	0.51	-0.94	-0.96		-0.29	-0.25	-0.61	-0.61	0.08	0.07	0.07	0.02	0.16	0.52	-0.57	-0.61	0.3	0.3	-0.51	-0.87	0.42	0.03	0.45	0.4
Retained Earnings	-0.69	-0.52	-0.95	0.58	0.29	-0.29		-0.65	-0.58	-0.58	-0.95	-0.04	-0.97	0.08	-0.98	-0.95	-0.62	-0.27	-0.96	-0.89	0.11	-0.13	-0.96	0.94	-0.95	-0.96
Accounts Payable	0.78	0.03	0.54	0.03	0.16	-0.25	-0.65		0.77	0.77	0.8	0.17	0.74	0.24	0.69	0.53	0.78	0.76	0.53	0.52	0.3	0.45	0.46	-0.84	0.44	0.49
Cash	0.99	0.26	0.36	0.33	0.56	-0.61	-0.58	0.77		1.0	0.73	-0.02	0.74	-0.1	0.68	0.36	1.0	0.77	0.55	0.48	0.37	0.83	0.43	-0.8	0.41	0.45
Cash And Short Term Investments	0.99	0.26	0.36	0.33	0.56	-0.61	-0.58	0.77	1.0		0.73	-0.02	0.74	-0.1	0.68	0.36	1.0	0.77	0.55	0.48	0.37	0.83	0.43	-0.8	0.41	0.45
Common Stock Total Equity	0.8	0.39	0.89	-0.37	-0.1	0.08	-0.95	0.8	0.73	0.73		0.0	0.99	-0.02	0.98	0.89	0.75	0.45	0.9	0.88	0.04	0.31	0.87	-0.98	0.86	0.88
Common Stock Shares Outstanding	-0.02	0.17	0.07	-0.08	-0.11	0.07	-0.04	0.17	-0.02	-0.02	0.0		0.02	-0.18	0.03	0.07	-0.02	-0.04	-0.02	-0.32	-0.47	-0.05	0.02	-0.01	0.02	0.01
Capital Surpluse	0.82	0.5	0.89	-0.38	-0.09	0.07	-0.97	0.74	0.74	0.74	0.99	0.02		-0.09	1.0	0.89	0.77	0.41	0.94	0.88	-0.01	0.33	0.91	-0.97	0.9	0.92
Other Current Assets	-0.11	0.01	-0.06	0.02	-0.07	0.02	0.08	0.24	-0.1	-0.1	-0.02	-0.18	-0.09		-0.1	-0.07	-0.1	0.12	-0.15	0.04	0.24	-0.06	-0.15	0.02	-0.15	-0.1
Other Stockholder Equity	0.76	0.53	0.93	-0.46	-0.16	0.16	-0.98	0.69	0.68	0.68	0.98	0.03	1.0	-0.1		0.93	0.71	0.33	0.96	0.89	-0.08	0.26	0.94	-0.95	0.94	0.94
Total Liab	0.48	0.5	1.0	-0.75	-0.51	0.52	-0.95	0.53	0.36	0.36	0.89	0.07	0.89	-0.07	0.93		0.4	0.07	0.94	0.88	-0.25	-0.11	0.97	-0.82	0.97	0.96
Total Current Assets	0.99	0.28	0.4	0.28	0.52	-0.57	-0.62	0.78	1.0	1.0	0.75	-0.02	0.77	-0.1	0.71	0.4		0.75	0.58	0.52	0.34	0.81	0.47	-0.82	0.45	0.49
Common Stock	0.73	-0.2	0.08	0.48	0.41	-0.61	-0.27	0.76	0.77	0.77	0.45	-0.04	0.41	0.12	0.33	0.07	0.75		0.24	0.23	0.77	0.54	0.09	-0.56	0.05	0.13
Non Current Assets Total	0.66	0.62	0.94	-0.57	-0.32	0.3	-0.96	0.53	0.55	0.55	0.9	-0.02	0.94	-0.15	0.96	0.94	0.58	0.24		0.9	-0.07	0.09	0.99	-0.87	0.98	0.99
Non Currrent Assets Other	0.58	0.39	0.88	-0.54	-0.29	0.3	-0.89	0.52	0.48	0.48	0.88	-0.32	0.88	0.04	0.89	0.88	0.52	0.23	0.9		0.11	0.06	0.89	-0.83	0.89	0.9
Other Assets	0.32	-0.45	-0.24	0.53	0.32	-0.51	0.11	0.3	0.37	0.37	0.04	-0.47	-0.01	0.24	-0.08	-0.25	0.34	0.77	-0.07	0.11		0.26	-0.22	-0.14	-0.25	-0.17
Non Current Liabilities Total	0.75	0.15	-0.11	0.68	0.91	-0.87	-0.13	0.45	0.83	0.83	0.31	-0.05	0.33	-0.06	0.26	-0.11	0.81	0.54	0.09	0.06	0.26		-0.01	-0.39	-0.03	-0.01
Property Plant And Equipment Net	0.55	0.64	0.97	-0.68	-0.42	0.42	-0.96	0.46	0.43	0.43	0.87	0.02	0.91	-0.15	0.94	0.97	0.47	0.09	0.99	0.89	-0.22	-0.01		-0.82	1.0	1.0
Retained Earnings Total Equity	-0.87	-0.36	-0.82	0.28	0.01	0.03	0.94	-0.84	-0.8	-0.8	-0.98	-0.01	-0.97	0.02	-0.95	-0.82	-0.82	-0.56	-0.87	-0.83	-0.14	-0.39	-0.82		-0.8	-0.83
Property Plant And Equipment Gross	0.53	0.64	0.97	-0.71	-0.43	0.45	-0.95	0.44	0.41	0.41	0.86	0.02	0.9	-0.15	0.94	0.97	0.45	0.05	0.98	0.89	-0.25	-0.03	1.0	-0.8		0.99
Property Plant Equipment	0.57	0.64	0.96	-0.67	-0.42	0.4	-0.96	0.49	0.45	0.45	0.88	0.01	0.92	-0.1	0.94	0.96	0.49	0.13	0.99	0.9	-0.17	-0.01	1.0	-0.83	0.99

Click cells to compare fundamentals

PAVmed Account Relationship Matchups

PAVmed fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	19.8M	87.0M	54.0M	33.1M	38.1M	23.6M
Other Current Liab	(15.0M)	4.3M	3.7M	6.6M	7.6M	8.0M
Total Current Liabilities	20.0M	7.6M	41.2M	54.2M	62.3M	65.4M
Total Stockholder Equity	1.9M	61.7M	(9.7M)	(53.8M)	(48.4M)	(46.0M)
Net Tangible Assets	(6.1M)	(641K)	57.2M	(15.8M)	(18.2M)	(17.3M)
Net Debt	(2.3M)	(77.3M)	(3.1M)	29.1M	26.2M	27.5M
Retained Earnings	(88.3M)	(138.9M)	(228.2M)	(294.4M)	(265.0M)	(251.7M)
Accounts Payable	3.0M	3.3M	2.7M	1.8M	2.1M	1.9M
Cash	17.3M	77.3M	39.7M	19.6M	22.6M	18.9M
Cash And Short Term Investments	17.3M	77.3M	39.7M	19.6M	22.6M	18.9M
Common Stock Total Equity	27.1K	40.5K	64K	86K	98.9K	103.8K
Common Stock Shares Outstanding	3.2M	5.2M	5.9M	7.2M	6.5M	6.9M
Liabilities And Stockholders Equity	19.8M	87.0M	54.0M	33.1M	38.1M	23.6M
Capital Surpluse	32.6M	47.6M	87.6M	198.1M	227.8M	239.2M
Other Current Assets	1.7M	5.2M	3.9M	3.8M	4.3M	4.1M
Other Stockholder Equity	87.6M	198.1M	215.9M	237.6M	273.2M	286.9M
Total Liab	20.3M	7.6M	43.0M	57.1M	65.7M	69.0M
Total Current Assets	18.9M	82.6M	43.9M	24.5M	28.2M	20.8M
Common Stock	64K	86K	95K	9K	10.4K	9.8K
Non Current Assets Total	837K	4.3M	10.1M	8.6M	9.9M	10.4M
Non Currrent Assets Other	755K	725K	1.1M	1.1M	1.3M	1.4M
Other Assets	837K	725K	1.1M	1.0	1.15	1.09
Non Current Liabilities Total	300K	4.3B	1.8M	3.0M	3.4M	3.2M
Noncontrolling Interest In Consolidated Entity	(161.5K)	(814.3K)	(2.4M)	17.8M	20.4M	21.4M
Retained Earnings Total Equity	(37.0M)	(53.7M)	(88.3M)	(138.9M)	(125.0M)	(118.8M)
Short Term Investments	262K	2.0M	3.0M	2.7M	3.1M	3.2M
Preferred Stock Total Equity	2.0M	2.3M	2.5M	2.4M	2.8M	1.9M
Property Plant Equipment	692.9K	82K	1.6M	5.5M	6.3M	6.6M
Short Long Term Debt Total	8.1M	15.0M	36.6M	48.7M	56.0M	58.8M
Net Invested Capital	14.3M	59.2M	21.3M	(12.6M)	(14.5M)	(13.8M)
Short Long Term Debt	8.1M	14.7M	33.7M	44.2M	50.8M	53.4M
Net Working Capital	(1.0M)	75.1M	2.7M	(29.7M)	(34.1M)	(32.4M)
Short Term Debt	8.1M	15.0M	34.8M	45.8M	52.6M	55.3M
Capital Stock	2.6M	2.5M	2.8M	3.0M	3.5M	2.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:

How To Invest In PAVmed

Details

Is PAVmed Stock a good investment?

Details

What is PAVmed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.14)

Revenue Per Share

0.45

Quarterly Revenue Growth

0.259

Return On Assets

(0.96)

Return On Equity

(13.58)

The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PAVmed Capital Surpluse vs Net Working Capital Analysis

Capital Surpluse vs Net Working Capital

Capital Surpluse vs Net Working Capital Correlation Analysis

Correlation Coefficient

Capital Surpluse

Net Working Capital

PAVmed fundamental ratios Correlations

PAVmed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PAVmed fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Stockholder Equity	+ 1.0	Capital Surpluse
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Retained Earnings Total Equity	- 0.98	Common Stock Total Equity
Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings Total Equity	- 0.97	Capital Surpluse
Capital Surpluse	- 0.97	Retained Earnings
Property Plant Equipment	- 0.96	Retained Earnings
Property Plant And Equipment Net	- 0.96	Retained Earnings